Suzanne Travers

8.3k citations
14 papers · 6.0k indexed · 3 hit papers · h-index 9

Suzanne Travers

14 papers receiving 5.8k citations

Hit Papers

Induction and Maintenance Infliximab Therapy for the Trea...662200420262011201850010001.5k2.0k2.5k

Peers

Suzanne Travers
Comparison fields: 5 of 110
  • Genetics 5.0k
  • Epidemiology 3.8k
  • Immunology 1.6k
  • Gastroenterology 396
  • Hematology 418
Replace Tim Wyant with:
Tim Wyant United States
Elena Ricart Spain
Jewel Johanns United States
Kimberly L. DeWoody United States
Maria Rosario United States
Fabian Schnitzler Germany
Stephan Targan United States
J F Colombel United States
Bruce Salzberg United States
Xavier Hébuterne France
Suzanne Travers relative to Tim Wyant United States Tim Wyant's profile →
Citations per field
00.5×1.5×1.9×
Tim Wyant · 1×
Citations per year

Countries citing papers authored by Suzanne Travers

Since Specialization
Citations

This map shows the geographic impact of Suzanne Travers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Travers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Travers more than expected).

Fields of papers citing papers by Suzanne Travers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Travers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Travers. The network helps show where Suzanne Travers may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Suzanne Travers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suzanne Travers Line = papers co-authored together Suzanne Travers links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 20143
2
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Childrenbreakdown →
2006662
3 2006155
4 200619
5 20055
6 20053
7
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitisbreakdown →
20052925
8 200539
9
Infliximab Maintenance Therapy for Fistulizing Crohn's Diseasebreakdown →
20041607
10 2004498
11 20032
12 19998
13 199916
14 199911

About Suzanne Travers

Suzanne Travers is a scholar working on Library and Information Sciences, Immunology and Allergy, Genetics, Hepatology and Epidemiology, having authored 14 papers that have together received 6.0k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (9 papers), Microscopic Colitis (7 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Autoimmune and Inflammatory Disorders (3 papers), Allergic Rhinitis and Sensitization (2 papers), Liver Diseases and Immunity (2 papers), Asthma and respiratory diseases (2 papers) and Mast cells and histamine (1 paper). The work is most often cited by research in Genetics (5.0k citations), Epidemiology (3.8k citations), Immunology (1.6k citations), Gastroenterology (396 citations) and Hematology (418 citations). Suzanne Travers has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include Paul Rutgeerts, Allan Olson, Brian G. Feagan, Daniel Rachmilewitz, Bruce E. Sands, Jewel Johanns, William J. Sandborn, Gary R. Lichtenstein, Jean‐Frédéric Colombel and Stephen B. Hanauer. Their work appears in journals such as The American Journal of Gastroenterology, New England Journal of Medicine, Gastroenterology, Chemical Senses and The Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026